|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/04 | |
| C07K 7/08 |
| (11) | Number of the document | 2790715 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11817532.2 |
| Date of filing the European patent application | 2011-12-13 | |
| (97) | Date of publication of the European application | 2014-10-22 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2011/003256 |
| Date | 2011-12-13 |
| (87) | Number | WO 2013/088194 |
| Date | 2013-06-20 |
| (72) |
MULLER, Sylviane, FR
BRIAND, Jean-Paul, FR
ZIMMER, Robert, FR
|
| (73) |
Centre National de la Recherche Scientifique,
3, rue Michel Ange, 75794 Paris Cedex 16,
FR
ImmuPharma France SA, 5, rue du Rhōne, 68100 Mulhouse, FR |
| (54) | MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES |
| MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES |